O. Dorofeeva, K. Zakharov, A. Grigoriev, V. Vasilyuk, A. Sidorova, A. Piven, N. Ivashkina, A. Globenko, A. Kapashin, O. Kovchan, M. Pasko
{"title":"Ranquilon®在健康志愿者中的药代动力学、安全性和耐受性评估:一项I期临床试验。","authors":"O. Dorofeeva, K. Zakharov, A. Grigoriev, V. Vasilyuk, A. Sidorova, A. Piven, N. Ivashkina, A. Globenko, A. Kapashin, O. Kovchan, M. Pasko","doi":"10.32756/0869-5490-2023-1-49-55","DOIUrl":null,"url":null,"abstract":"Comparative evaluation of the pharmacokinetics, safety profile and tolerability of Ranquilon® 1 mg tablets with a single administration under fasting and fed conditions among healthy male and female volunteers.","PeriodicalId":10353,"journal":{"name":"Clinical pharmacology and therapy","volume":"18 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-02-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Evaluation of Ranquilon® pharmacokinetics, safety profile and tolerability in healthy volunteers: a phase I clinical trial.\",\"authors\":\"O. Dorofeeva, K. Zakharov, A. Grigoriev, V. Vasilyuk, A. Sidorova, A. Piven, N. Ivashkina, A. Globenko, A. Kapashin, O. Kovchan, M. Pasko\",\"doi\":\"10.32756/0869-5490-2023-1-49-55\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Comparative evaluation of the pharmacokinetics, safety profile and tolerability of Ranquilon® 1 mg tablets with a single administration under fasting and fed conditions among healthy male and female volunteers.\",\"PeriodicalId\":10353,\"journal\":{\"name\":\"Clinical pharmacology and therapy\",\"volume\":\"18 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-02-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical pharmacology and therapy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32756/0869-5490-2023-1-49-55\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical pharmacology and therapy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32756/0869-5490-2023-1-49-55","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Evaluation of Ranquilon® pharmacokinetics, safety profile and tolerability in healthy volunteers: a phase I clinical trial.
Comparative evaluation of the pharmacokinetics, safety profile and tolerability of Ranquilon® 1 mg tablets with a single administration under fasting and fed conditions among healthy male and female volunteers.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
